WO2025003977 - IN VITRO TRANSCRIPTION METHOD

National phase entry is expected:
Publication Number WO/2025/003977
Publication Date 02.01.2025
International Application No. PCT/IB2024/056309
International Filing Date 28.06.2024
Title **
[English] IN VITRO TRANSCRIPTION METHOD
[French] PROCÉDÉ DE TRANSCRIPTION IN VITRO
Applicants **
SEQIRUS INC.
Inventors
CHANG, Cheng
Priority Data
63/510,969   29.06.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2596
EPO Filing, Examination, Granting18528
Japan Filing, Examination, Granting2689
South Korea Filing, Examination, Granting3190
USA Filing, Examination, Granting10910
MasterCard Visa
Total: 37,913

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present disclosure relates generally to methods of producing RNA from a DNA template. More particularly, the method of the present disclosure comprises an in vitro transcription method for producing RNA from close-ended DNA (ceDNA) templates.[French] La présente divulgation concerne de manière générale des procédés de production d'ARN à partir d'une matrice d'ADN. Plus particulièrement, le procédé de la présente divulgation comprend un procédé de transcription in vitro pour produire de l'ARN à partir de matrices d'ADN à extrémité fermée (ADNce).